Growth is driven by the rising prevalence of diabetes among the elderly, necessitating efficient insulin delivery solutions ...

Column chart showing Novo Nordisk shares monthly percentage change ... fund manager at healthcare-focused Bellevue Asset Management in Switzerland, which holds Novo shares, said he and other ...

President Donald Trump has ordered the Department of Health and Human Services to standardize Medicare payments in an effort ...

Trump previously floated a 25% tariff on all imported drugs, though they were unaffected by recent reciprocal levies.

Stocks in drugmakers sold off globally after President Trump said tariffs on pharmaceutical imports will be unveiled shortly, ...

LONDON (Reuters) -Novo Nordisk shares have fallen 25% so far ... fund manager at healthcare-focused Bellevue Asset Management in Switzerland, which holds Novo shares, said he and other investors ...

Advances recognized by science’s most lucrative awards include high-energy physics experiments and groundbreaking weight-loss ...

Novo Nordisk’s bid to provide a once-weekly ... Australia, Japan, and Switzerland under the Awiqli brand name, as well as in China. Eli Lilly is its nearest rival, developing a once-weekly ...

Pharmaceutical giants, such as Denmark’s Novo Nordisk, Switzerland’s Roche and France’s Sanofi, have substantial US sales footprints but so far remain exempt from the tariff regime.

Novo Nordisk got the go-ahead for its once-daily ... and has also been given a green light in Australia, Japan, Switzerland, and the EU. Both are vying for market share with Roche's near $5 ...

By Maggie Fick and Lucy Raitano LONDON (Reuters) -Novo Nordisk shares have fallen 25% so far in March and are on track for their biggest monthly drop since July 2002, as investor worries intensify ...